title: Continuous administration of sorafenib in combination with transarterial chemoembolization in patients with hepatocellular carcinoma: results of a phase I study.
authors.affiliation: University Clinic for Visceral Surgery and Medicine, University of Berne, CH-3010 Berne, Switzerland. jf.dufour@insel.ch
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Dufour
authors.forename: Hanno
authors.initials: H
authors.lastname: Hoppe
authors.forename: Markus H
authors.initials: MH
authors.lastname: Heim
authors.forename: Beat
authors.initials: B
authors.lastname: Helbling
authors.forename: Olivier
authors.initials: O
authors.lastname: Maurhofer
authors.forename: Zsolt
authors.initials: Z
authors.lastname: Szucs-Farkas
authors.forename: Ralph
authors.initials: R
authors.lastname: Kickuth
authors.forename: Markus
authors.initials: M
authors.lastname: Borner
authors.forename: Daniel
authors.initials: D
authors.lastname: Candinas
authors.forename: Bettina
authors.initials: B
authors.lastname: Saar
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D024221:Antineoplastic Protocols; D001557:Benzenesulfonates / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000628:therapy*; D002408:Catheters, Indwelling; D016461:Chemoembolization, Therapeutic; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000628:therapy*; D016685:Mitomycin / Q000627:therapeutic use; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D011725:Pyridines / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D000077157:Sorafenib; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000097:blood
chemical_list: D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D011725:Pyridines; D042461:Vascular Endothelial Growth Factor A; D009536:Niacinamide; D016685:Mitomycin; D004317:Doxorubicin; D000077157:Sorafenib